NanoMedSyn
Research - Montpellier, Occitanie, France
NanoMedSyn Employees
NanoMedSyn Details
NanoMedSyn develops new targeted therapeutics to treat Lysosomal Storage Disorders. Thanks to proprietary synthetic derivatives (named AMFA), NanoMedSyn provides a compound with an high affinity for the mannose 6-phosphate receptor, responsible for the targeting of enzymes to the lysosome. A new generation of enzymes for the therapy of Lysosomal Diseases is now possible.
Website:
http://www.nanomedsyn.com
Employees:
7
HQ:
+33 4 1175 9617
Location:
Montpellier, Occitanie, France
Revenue:
NanoMedSyn Technologies
Load Balancers
Apache
CMS
WordPress.org
Search Appliances
Google Custom Search
Other
Mobile Friendly